Revuforj gets FDA priority review for AML with NPM1 mutations
U.S. regulators have granted priority review to Syndax’s application…
Blood cancer is a broad term encompassing diseases in which blood cells grow too much or develop abnormally. Typically, blood cancers are classified into three main categories – leukemia, lymphoma, and myeloma – but they can be further divided into dozens of specific types, each with unique features.
Read moreA wide range of therapies are available for treating blood cancer, from chemotherapy and targeted therapy to radiation, stem cell transplant, and surgery. When devising a suitable treatment plan for blood cancer, healthcare providers take into account various factors, such as age, overall health, the specific type of blood cancer, and potential treatment side effects.
Read moreU.S. regulators have granted priority review to Syndax’s application…
The U.S. Food and Drug Administration (FDA) has approved…
Nearly 1 in 4 people with NPM1-mutated acute myeloid…
A team led by a Rice University researcher…
The first participant in a U.S. Phase 1 clinical…
ELVN-001, an experimental treatment for chronic myeloid leukemia (CML), a…